The document discusses the bioPmed cluster initiative in Italy's Piedmont region, which brings together companies, universities, and research centers working in life sciences and medical technologies. The initiative takes a strategic approach to personalized medicine focusing on converging multiple technologies. This includes areas like biotech, medical devices, ICT, and others. The goal is to develop innovative solutions for healthcare by combining diverse technological expertise. BioPmed has over 80 core members and works internationally with other clusters through partnerships and shared projects.
75 companies from Belgium are exhibiting at BIO 2014, the largest convention on biotech. Discover inside our companies from Flanders with top innovative and top well known biotech know how.
“Key messages for policy makers” presented at the "H2020 projects for evidence-based agricultural related policies" roundtable at the European Parliament on the 25th April 2018.
Do not hesitate to contact EMPHASIS project through:
Facebook https://www.facebook.com/emphasisproject/
Twitter https://twitter.com/EmphasisProject
Email emphasisproject@gmail.com
Website http://www.emphasisproject.eu
Slideshare https://www.slideshare.net/EMPHASISPROJECT/
75 companies from Belgium are exhibiting at BIO 2014, the largest convention on biotech. Discover inside our companies from Flanders with top innovative and top well known biotech know how.
“Key messages for policy makers” presented at the "H2020 projects for evidence-based agricultural related policies" roundtable at the European Parliament on the 25th April 2018.
Do not hesitate to contact EMPHASIS project through:
Facebook https://www.facebook.com/emphasisproject/
Twitter https://twitter.com/EmphasisProject
Email emphasisproject@gmail.com
Website http://www.emphasisproject.eu
Slideshare https://www.slideshare.net/EMPHASISPROJECT/
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Canada:
Personalised Medicine: A Canadian Collaborative Perspective'
Dr Étienne Richer, Assistant Director at CIHR Institute of Genetics
=======================================
http://www.eurobioforum.eu
Regional Development in Ukraine - best practiceJacques Bazen
Presentation in Kiev Oblast State Administration, for the "Centre for training and advanced education of employees, public authorities, local governments, public enterprises, institutions and organizations in Kyiv Oblast State Administration".
The presentation deals with regional development of smaller non capital cities, with a best practice of the restructuring of the economy of the city of Enschede in the eastern part of The Netherlands, from mono-industrial city to a more diversified innovation driven economy. The second half of the presentation deal with the necessary political and economic preconditions for Ukraine to get real and sustainable economic development in its regions (based on the theory from Why nations fail of Acemoglu & Robinson).
EuroBioForum 2013 - Day 1 | Wolfgang EberleEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Belgium
Working across disciplines for our health benefit - From successful strategies for biotech and nanotech to Nanotech for Health in Flanders
Wolfgang Eberle
Funded Program Manager Life Science Technologies Imec
=======================================
http://www.eurobioforum.eu
Paving the way for eHealth, active ageing and independent living products and...Haivisio CSA project
Paving the way for eHealth, active ageing and independent living products and services generated by European Research & Innovation projects
Markku Markkula
Juli Mylona - Bioconomy - plant science and agriculture. Future funding under...epsoeurope
Presentation from Juli Mylona, Directorate FAFB, DG Research and Innovation, European Commission, at the 7th EPSO Conference, 2 Sept 2013.
"Bioconomy - plant science and agriculture. Future funding under Horizon 2020"
Promoting the creation, relocation and development of biotech companies
From a Bio-Park to a Bio-Cluster ...
a Biopark fully integrated in the Medicen Paris Region Bio-cluster
Building the most favorable environment to develop Biotech companies…
Belgium at Bio San Diego USA 2014 : WBC Incubator is there!STRATAG'M Sprl
Among the 300 existing in Belgium in the field of Biotech companies, discover here, the 75 participating companies had the largest fair in the world of biotechnology: BIO 2014 @ SAN DIEGO!
Among these 75 participants, discover WBC Incubator, the company incubator of life sciences Wallonia!
"Where Agri Meets Tech, Driving Research to Market" Ultan O’Raghallaigh Asia Matters
Ultan O’Raghallaigh of Tyndall National Institute gave the speech at the Asia Ireland Food and Agritech Forum in Cork, 14 July as part of Asia Business Week Ireland 2015
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Canada:
Personalised Medicine: A Canadian Collaborative Perspective'
Dr Étienne Richer, Assistant Director at CIHR Institute of Genetics
=======================================
http://www.eurobioforum.eu
Regional Development in Ukraine - best practiceJacques Bazen
Presentation in Kiev Oblast State Administration, for the "Centre for training and advanced education of employees, public authorities, local governments, public enterprises, institutions and organizations in Kyiv Oblast State Administration".
The presentation deals with regional development of smaller non capital cities, with a best practice of the restructuring of the economy of the city of Enschede in the eastern part of The Netherlands, from mono-industrial city to a more diversified innovation driven economy. The second half of the presentation deal with the necessary political and economic preconditions for Ukraine to get real and sustainable economic development in its regions (based on the theory from Why nations fail of Acemoglu & Robinson).
EuroBioForum 2013 - Day 1 | Wolfgang EberleEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Belgium
Working across disciplines for our health benefit - From successful strategies for biotech and nanotech to Nanotech for Health in Flanders
Wolfgang Eberle
Funded Program Manager Life Science Technologies Imec
=======================================
http://www.eurobioforum.eu
Paving the way for eHealth, active ageing and independent living products and...Haivisio CSA project
Paving the way for eHealth, active ageing and independent living products and services generated by European Research & Innovation projects
Markku Markkula
Juli Mylona - Bioconomy - plant science and agriculture. Future funding under...epsoeurope
Presentation from Juli Mylona, Directorate FAFB, DG Research and Innovation, European Commission, at the 7th EPSO Conference, 2 Sept 2013.
"Bioconomy - plant science and agriculture. Future funding under Horizon 2020"
Promoting the creation, relocation and development of biotech companies
From a Bio-Park to a Bio-Cluster ...
a Biopark fully integrated in the Medicen Paris Region Bio-cluster
Building the most favorable environment to develop Biotech companies…
Belgium at Bio San Diego USA 2014 : WBC Incubator is there!STRATAG'M Sprl
Among the 300 existing in Belgium in the field of Biotech companies, discover here, the 75 participating companies had the largest fair in the world of biotechnology: BIO 2014 @ SAN DIEGO!
Among these 75 participants, discover WBC Incubator, the company incubator of life sciences Wallonia!
"Where Agri Meets Tech, Driving Research to Market" Ultan O’Raghallaigh Asia Matters
Ultan O’Raghallaigh of Tyndall National Institute gave the speech at the Asia Ireland Food and Agritech Forum in Cork, 14 July as part of Asia Business Week Ireland 2015
Status of the Microfluidics Industry 2019 report by Yole Développement Yole Developpement
Diversification of microfluidic technologies has led to burgeoning new applications and market growth, driving players’ interest and M&A.
More information on https://www.i-micronews.com/products/status-of-the-microfluidics-industry-2019/
The Biocat Report is the first specific study focusing on the biotechnology, biomedicine and medical technology sector in Catalonia, created by the Biocat team with collaboration from a number of experts from the sector.
In Rizzoli Orthopedic Institute a long regenerative medicine tradition is established. Among all countless projects ongoing in the Institute, the hospital joins the regenerative clinical arena with 3 big national and international initiatives: project Orthounion, an innovative approach to manage non-consolidated fractures, based on autotransplantation of GMP expanded bone marrow mesenchymal stem cells; Italian Regenerative Medicine Infrastructure (IRMI), public-private national network with the mission to push innovation and increase international competitiveness of Italian industries and institutes; Rizzoli Cell Factory, the first public department in Italy implementing a Class A clean room-based facility, which is today reshaping its operative models with innovative technologies that will grant more productivity and more dynamicity in developing innovative therapies.
Project web site: www.custom-implants.it
Presentations and videos: cerr.eu/what-s-going-on/357-materiali-dei-seminari-disponibili-online
Further materials: www.slideshare.net/CERRicerca
Similar to EuroBioForum 2013 - Day 2 | Alberto Baldi (20)
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Genome British Colombia, Canada:
Regional Perspectives on Personalized Medicine in British Columbia, Canada
Dr Rachael Ritchie
Director Business Development Genome British Colombia
=======================================
http://www.eurobioforum.eu
The heart of life sciences full reportEuroBioForum
This report invites you to read more about why Denmark is a unique laboratory for healthcare and welfare
technology, and why Denmark is an excellent place to do business.
EuroBioForum 2013 - Day 2 | Jami TaylorEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# KEYNOTE PRESENTATION #
Personalised medicine education & training
Macro challenges and the path forward
Jami Taylor
Senior Director, Global Access Policy at Janssen, the Pharmaceutical Companies of Johnson & Johnson
Vice-chair of the Education Committee of EPEMED
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Pelagiya DragomirovaEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# EARLY BIRD TALK #
The social media & web technology boost - intruder or trigger?
Pelagiya Dragomirova
Communications Advisor at Publimarket
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
EuroBioMed, France:
Private-public collaborations to boost open innovation
Dr Franck Molina
President of EDCA, Chair of diagnosis group of Eurobiomed
Director of Sysdiag
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Mark PoznanskyEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Ontario Genomics Institute, Canada:
Innovative Research, Innovative Translation
Dr Mark Poznansky
President and CEO Ontario Genomics Institute
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Marc LapageEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Genome Quebec, Canada:
Personalised medicine – Reaching the patient?
Marc LePage
President and CEO Genome Quebec
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Rotterdam Delta, The Netherlands:
What’s keeping medicine from becoming personalised?
Dr Menno Kok,
Advisor Research Strategies Erasmus MC and sector manager Medical Delta
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 1 | Pierre MeulienEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Canada:
Genomics and personalised health in Canada
Dr Pierre Meulien, President and CEO at Genome Canada
=======================================
http://www.eurobioforum.eu
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
2. / 2Bioindustry Park 2013– All Rights Reserved
Alberto Baldi
baldi@bioindustrypark.it
Munich, May 28th, 2013
bioPmed, a step beyond personalised
medicine
3. / 3Bioindustry Park 2013– All Rights Reserved
Piemonte cluster and Bioindustry Park
Silvano Fumero
Key trends
bioPmed cluster initiative
bioPmed strategic approach
Concept scale-up
Take away messages and offer
CONTENTS
4. / 4Bioindustry Park 2013– All Rights Reserved
Torino
Verbania
Biella Novara
Vercelli
Alessandria
Cuneo
Asti
4.4 million inhabitants
€ 123.4 billion GDP
€ 38.5 billion export
467,500 companies
€ 2.2 billion R&D investments
1,000 R&D contracts
220 R&D centers, 380 Labs
6 Science & Technology Parks
4 Universities
Strong relationships with
other European Regions
1st region in Italy for:
Private R&D investment
Hi-tech patents
ITALY: PIEMONTE REGION
5. / 5Bioindustry Park 2013– All Rights Reserved
Science Park focused on life sciences, created with the support of
Regione Piemonte in the EU programs framework (beginning 90’s) -
Operational since 1998.
It hosts more than 30 organizations
Managing company of the Innovation Cluster bioPmed
Member of national and international networks
22.000 sqm labs, office spaces
R&D shared facilities
R&D scientific services (Able
Biosciences initiatives)
1 incubator
Consultancy in biomanagement
Conference centre
www.bioindustrypark.eu
Offer
BIOINDUSTRY PARK SILVANO FUMERO
6. / 6Bioindustry Park 2013– All Rights Reserved
KEY TRENDS
• Health care is a priority for all actors of the value chain
– Societal needs
– Cost pressure
– Lead markets (e.g. Ageing, metabolic diseases, cancer, CNS, etc)
– Political priority (Horizon 2020)
• The paradigm for health care is changing
– From a “pill for all” to a personalised approach
– From an acute problem to a managed problem
– From local development to global value creation networks
– From a “mono-technoligical” approach to a converging
technologies approach (Es. diagnostic + therapies + devices
altogether)
• The health care sector has now a global, multi-
technological and trans-market dimension, touching also
different “traditional” sectors, from agro-food to ICT.
7. / 7Bioindustry Park 2013– All Rights Reserved
A EU “world class cluster” dedicated to bio and medical technologies –
created in 2009
A core founder of the ALISEI (Advanced LIfe SciEnces in Italy) national
cluster that involves 13 different regional actors
80+
CORE
MEMBERS
370+
ENLARGE
COMMUNITY
National &
International Hubs
The bioPmed
Community
A shared smart approach for
innovation:
converging technologies
BIOPMED CLUSTER INITIATIVE
“Overlapping different
technological knowledge
to reach innovative
solutions to ensure a
better future”
Synergies with local
clusters (ICT, New
materials,
textiles...), with EP
and non EP clusters
∼200 health care
132 R&D centers
3924 scientists
Companies, Universities,
R&D centers, foundations
8. / 8Bioindustry Park 2013– All Rights Reserved
Project
building
Working
groups
Community
building
Shared
access to
infrastructures
(material /
immaterial)
R&D
Projects
Added
value shared
services
International networking International clusters
Governance – Labeling
Regional
financing
Events organisation and participation, information,
opportunities and support to single companies, universities
and agencies in sectorial internationalisation
Council of European
Bioregions
International projects
International agreements
Soft landing agreements
SMEs INTERNATIONALISATION AND
THE CLUSTER ENVIRONMENT: BIOPMED APPROACH
9. / 9Bioindustry Park 2013– All Rights Reserved
bioPMed obtained the “Bronze Label”
from the European Secretariat for Cluster
Analysis”
bioPmed ranked 1st in a national
performance evaluation of clusters and
science parks
Source: “Dai distretti industriali ai poli di innovazione.
L'Italia nel Mediterraneo, M. Ferarra, R. Mavilia EGEA,
2012”
Companies contacted and involved 330
Scientist contacted and involved 3500
Organizations formally and
contractually linked
82
Total output project building
activities
143
Technical work-shops organized 34
Companies involved in
internationalisation and international
activities
147
Advanced services financed 15
Feasibility studies and R&D
projects financed
29
EU funded project ongoing and
presented
10
% of members involved in projects
(cumulative)
100%
Overall value of initiatives linked to
cluster activities
20.860.231
Involvement in institutional advisory
board external to the region
4
BIOPMED: PERFORMANCES
10. / 10Bioindustry Park 2013– All Rights Reserved
Genomics,
Biochemistry,
Molecular
&cellularbiology
Diagnostic
&Theranostics
Electronical,medical
&laboratory
equipment
Medicalbiomaterials
Medicaltechnology
&Biomedical
engineering
Functionalfood
Microbiological
consortia
Computersciences
Disease Prevention ROTARIC ATHIMAG
SAFE TAN
SUN TAN
PREVI
IaRO
ROTARIC
Nutratec
MicoDiaBreas
t
ARAS
BACOSTE
Prothesis, biomedical
Devices/instrumenta
tion
& drug delivery
BIOBONE
CARDIOMITRAL
SWAP
SiNplant
Self exp. DES
TINET; I.B.G.
IPEEI
BONEJECT
KEME
PIEDMONT
BIOMAG
ANTIBACOSS
Dense-gas CRYO
CRYOPHARMA
NANOSTENT
FIDIS
BIOMICROFAB
DESTINI
WILOP; JIGTO
FACE; ORECO
BIOMAG
NeuroVirtual3D
Nuvola3D
RICCAmente
Regenerative
Medicine MOSQUITO
HYPERSPECTRA
STELLA
BICONerve
TINET; I.B.G.
QUANTADIPO
BONEJECT
PIEDMONT
ANTIBACOSS
PLA scaffolds
NanoStem
B.B.S.
FACE
WEB BI
Pharmaceutical
TAB2
NOVADEP
TLR7A
ERP
NATIMAB
ATHEROVAX
PSSEIK
Personalized
Molecular Medicine MOSQUITO
GNRs
Pred_HEALTH
FaPre
P-MOSP
Diagnostic
EPIgenetic screening
NuGeSa
FAST
Beta-agonist detection
DMS; Bioprotech
ATHIMAG
HYPERSPECTRA; STELLA
LOCHTECH
MicroDiBi
PROMOTECO
BANP.
TrCD; Idata
E_LAB; FAST
P-MOSP
Veterinary
FLUOMAG
CANESTRO
Specialisation fields have
been derived from company
based projects
11. / 11Bioindustry Park 2013– All Rights Reserved
EAPB
Biobay,
Scientific
Park
FABA
Federation of
Asian Biotech
Associations
CBS
FR: Lyonbiopole; ADEBAG; Eurobiomed; Genopole;
I-Care
DE: BioM; Technologiepark Heidelberg, bioTop
PL: Wrocław Center for S&T in Medicine
ES: BioCAT; Parque Tecnologico di Vizkaia
IT: Toscana Life Sciences
CH: BioAlps ; DK: MVA
UK: One Nucleus; SWE:
Stockolm Science City
Technology
Centre of New
Jersey
Israel
BioNegev cluster;
RAD biomed
BioCulture
FIPASE
eLSi
BIOPMED: INTERNATIONAL NETWORK AND PROJECTS
12. / 12Bioindustry Park 2013– All Rights Reserved
The “traditional approach”
(One problem, one technology, one solution)
The “bioPmed smart approach”
(Converging technologies)
- Up to 250 companies working specifically in
health care
- Over xx.000 companies working in ICT,
Mechatronics, New Materials, textiles, etc
80+ bioPmed cluster CORE MEMBERS
share the approach of a smart Healthcare cluster aiming at
“Overlapping different technological knowledge to reach innovative
solutions to
unmet medical needs and ensure a better future”
THE BIOPMED SMART APPROACH
13. / 13Bioindustry Park 2013– All Rights Reserved
BIOENGINEERING
BIOLOGY
ENGINEERING
COMPUTER
SCIENCE
NANOTECHNOLOGY
BIOLOGY
ENGINEERING
CHEMISTRY
PHYSICS
COMPUTER
SCIENCE
BIO MECHATRONICS
MECHANICAL
ENGINEERING
ELECTRICAL
ENGINEERING
COMPUTER
SCIENCE
PERVASIVE COMPUTING
This includes
engineering, computer
science and all of the
liberal arts
MATERIAL SCIENCE
MATERIAL
ENGINEERIN
G
CHEMISTRY
PHYSICS
* Source: Proceedings of the 2002 American Society for Engineering Education Annual Conference & Exposition
Copyright 2002, American Society for Engineering Education
BIOLOGY
BASED ON CONVERGING TECHNOLOGIES
14. / 14Bioindustry Park 2013– All Rights Reserved
AND A STRATEGIC PERSPECTIVE
• While the current, almost “traditional”, concept of Personalised
Medicine stands for the customisation of healthcare for patient
subgroups through medical decisions, practices and products,
the future will be probably the development of a Personalised
Healthcare with a solution-driven approach, bringing together
the necessary industry sectors.
• This shall not only involve therapeutics and diagnostics research
& development, but also include other technological
approaches for the lifelong management of health and
healthcare, like e-Health (patient care using IT solutions and
devices), medical technologies, new materials, electronics and
mechatronics, but also the involvement of “traditional” low-
medium tech sectors such as agro-food, cosmetics and textiles.
15. / 15Bioindustry Park 2013– All Rights Reserved
WORKING ON LINKS BETWEEN DIFFERENT TECHNOLOGICAL &
MARKET FIELDS
Therapy Diagnostic Med-tech CosmeticHealth systems Food
Personalised medicine
Personalised health care approach
Key Enabling Technologies (KET) and Future Emerging Technologies (FET)
R&D, Industry, PAs, Users
T
e
c
h
n
o
l
o
g
i
e
s
16. / 16Bioindustry Park 2013– All Rights Reserved
To develop a common and joint internationalisation strategy for the
4 Life Sciences Clusters, in order to reinforce the European SMEs’
competitiveness outside Europe
Mutualising and sharing internationalisation tools (programs,
practices, networks) already implemented to obtain economy of
scale/knowledge
Identifying the most efficient tools for SMEs’ competitiveness on the
global market
Testing common pilot actions towards 3 targeted markets: Brazil,
China, United States
Reinforcing the visibility of the 4 European Life Sciences Clusters
together and European competences worldwide
ERAI (Rhône-Alpes, FR)
Project Leader
Lyonbiopole (Rhône-Alpes, FR)
Host Cluster
BioCat (Catalonia, SP)
Invited Cluster
BioM (Bayern Region, DE)
Invited Cluster
BioPmed (Piedmont, IT)
Invited Cluster
www.bioxcluster.com
AN INTERNATIONAL PLATFORM BASED ON A SHARED VISION
17. / 17Bioindustry Park 2013– All Rights Reserved
A POSSIBLE FURTHER STEP: A STRATEGIC CLUSTER
PARTNERSHIP FOR PERSONALIZED MEDICINE
bioXclusters as the common starting platform to involve
other European health clusters to develop a strong
European Alliance on Personalised Healthcare
The Strategic Cluster Partnership (ESCP) initiative with a focus on
Personalised Healthcare
5 different market-oriented clusters (bioPmed, Lyonbiopole,
BioM, BioCat and Health Science Scotland, 3 with quality
assessed ESCA Bronze label, 4 involved in a world class cluster
project, bioXclusters)
A common strategic agenda based on an intersectorial
converging technologies approach
First step of evaluation already passed
A global vision:
Today
US
China
Brazil
and in the future…
Korea
Japan
North Africa
18. / 18Bioindustry Park 2013– All Rights Reserved
The health care paradigm is changing:
Cost factor
Technology advancements
Societal needs
bioPmed is leveraging on all available technologies in order to
develop - through R&D projects - solutions to such challenges
bioPmed is using the power of partnership to work together
with key clusters in Europe to create a pan European platform -
based on a personalised healthcare vision - that could act as a
real global actor.
TAKE AWAY MESSAGES
19. / 19Bioindustry Park 2013– All Rights Reserved
Try to think big and on the long term
Life Long health management should be
the paradigm
Work on the integration of healthcare
systems at European Level
TOP 3 RECOMMENDATIONS FOR ACHIEVING TANGIBLE RESULTS
20. / 20Bioindustry Park 2013– All Rights Reserved
A solution-oriented approach, based on the
integration of multiple technological
domains
An international vision and development
strategy based on partnerships and
complementarities
WHAT CAN WE OFFER
21. / 21Bioindustry Park 2013– All Rights Reserved
Partners sharing our vision and approach
Ready to work on a global scale
WHAT ARE WE LOOKING FOR
22. / 22Bioindustry Park 2013– All Rights Reserved
BIO-Europe Spring®
will be organised
in Turin (Piemonte)
March 10–12, 2014
http://www.ebdgroup.com/bes/program/index.php
BIO-EUROPE SPRING® 2014
23. Bioindustry Park Silvano Fumero S.p.A.
Alberto Baldi
DBusiness Development and International projects
baldi@bioindustrypark.it
Via Ribes, 5
10010 Colleretto Giacosa (TO)
ITALY
Tel. +39-0125-561311
info@biopmed.eu
www.biopmed.eu
www.bioindustrypark.euIt is the team that wins
not the single player…..